IDH2 and acute myeloid leukemia: Furthermore, the differential responsiveness and “alloreactivity” of single IDH subclasses to alloHCT in CR1 should initiate further prospective investigations to validate these findings, especially in respect of co-mutational patterns influencing the predictive value of IDH mutations, offering the chance to add information for refined AML risk classifications to improve survival for AML patients.